<DOC>
	<DOCNO>NCT00002337</DOCNO>
	<brief_summary>To evaluate safety tolerability four dose oral vesnarinone patient advance HIV disease .</brief_summary>
	<brief_title>A Study Multiple Doses Vesnarinone Advanced HIV Disease</brief_title>
	<detailed_description>Fourteen patient per dose level receive vesnarinone 1 4 dos 12 week . At least seven patient give dose level must complete 4 week treatment dose escalated subsequent patient .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Vesnarinone</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Chemoprophylaxis Pneumocystis carinii , candida , mycobacteria , opportunistic infection . Acyclovir 14 day acute herpes outbreak . Patients must : Documented HIV infection . CD4 count 50 300 cells/mm3 . No active opportunistic infection . No fever , diarrhea , Herpes zoster . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Clinically significant current cardiac disease , include patient exhibit long QTC syndrome EKG screen abnormal cardiothoracic ratio chest xray baseline . Active malignancy ( cutaneous Kaposi 's sarcoma cutaneous basal cell carcinoma situ carcinoma cervix ) . Concurrent Medication : Excluded : Antiretroviral agent , include ddI , ddC , AZT , d4T . Immunosuppressive agent . Investigational HIV drugs/therapies include vaccine . Interferon immunomodulating agent . Corticosteroids ( topical ) . Hematopoietins . Megestrol acetate . Agents know cause neutropenia . Trimethoprim/sulfamethoxazole excess 160 mg trimethoprim 800 mg sulfamethoxazole thrice weekly . Cytotoxic chemotherapy . Concurrent Treatment : Excluded : Radiation therapy . Patients follow prior condition exclude : Prior history cardiac disease . History agranulocytosis severe ( grade 3 worse ) druginduced neutropenia document abnormality granulocyte function . Prior Medication : Excluded : AZT , ddI , ddC , d4T , nucleoside analog antiretroviral therapy within 14 day prior study entry . Prior cytotoxic chemotherapy . Acyclovir herpes prophylaxis within 48 hour prior study entry . Prior Treatment : Excluded within 30 day prior study entry : Erythropoietin , transfusion , blood product use . Radiation therapy ( include electron beam irradiation ) . Active use illicit drug ( specifically cocaine , amyl nitrate , heroin , cardioactive agent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 1996</verification_date>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>vesnarinone</keyword>
</DOC>